Trulieve Cannabis (TCNNF) Cash from Investing Activities (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Cash from Investing Activities of -$13.2 million in Q1 2026, down 123.75% quarter-over-quarter from -$5.9 million in Q4 2025, and down 130.66% on a YoY basis from $43.0 million in Q1 2025.
Trulieve Cannabis (TCNNF) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$13.2 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 130.66% year-over-year to -$13.2 million; the TTM figure through Mar 2026 stood at -$42.7 million (up 70.47% YoY), while the FY2025 annual figure was $13.5 million, up 106.53% from the prior year.
- Cash from Investing Activities was -$13.2 million for Q1 2026 at Trulieve Cannabis, down from -$5.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $43.0 million in Q1 2025 to a low of -$131.5 million in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$27.0 million across 5 years, with a median of -$18.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities sank 2535.15% in 2024, then soared 326.88% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$36.1 million in 2022, then soared by 80.14% to -$7.2 million in 2023, then plunged by 223.67% to -$23.2 million in 2024, then jumped by 74.57% to -$5.9 million in 2025, then tumbled by 123.75% to -$13.2 million in 2026.
- The last three Cash from Investing Activities figures came in at -$13.2 million (Q1 2026), -$5.9 million (Q4 2025), and -$15.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | -13.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.19 Mn |
| Mar 31, 2026 | -13.19 Mn |
| Dec 31, 2025 | -5.89 Mn |
| Dec 31, 2025 | -5.89 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | -8.24 Mn |
| Jun 30, 2025 | -8.24 Mn |
| Mar 31, 2025 | 43.02 Mn |
| Mar 31, 2025 | 43.02 Mn |
| Dec 31, 2024 | -23.18 Mn |
| Dec 31, 2024 | -23.18 Mn |
| Sep 30, 2024 | -131.49 Mn |
| Sep 30, 2024 | -131.49 Mn |
| Jun 30, 2024 | -32.98 Mn |
| Jun 30, 2024 | -32.98 Mn |
| Mar 31, 2024 | -18.96 Mn |
| Mar 31, 2024 | -18.96 Mn |
| Dec 31, 2023 | -7.16 Mn |
| Dec 31, 2023 | -7.16 Mn |